- About this Journal ·
- Abstracting and Indexing ·
- Advance Access ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Journal of Obesity
Volume 2013 (2013), Article ID 741097, 6 pages
Sleeve Gastrectomy and Gastroesophageal Reflux Disease
1Department of Surgery, University of Alberta, Edmonton, AB, Canada
2Center for the Advancement of Minimally Invasive Surgery (CAMIS), Edmonton, AB, Canada
Received 13 March 2013; Revised 18 June 2013; Accepted 18 June 2013
Academic Editor: Christine Stroh
Copyright © 2013 Michael Laffin et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Bariatric surgery, when combined with lifestyle and medical interventions, is a common and successful treatment modality in the obese patient. Laparoscopic sleeve gastrectomy is one such procedure that has increased in popularity as a definitive bariatric operation. Although laparoscopic sleeve gastrectomy has been shown to be effective in producing weight loss and improving type 2 diabetes mellitus, its effect on gastroesophageal reflux disease (GERD) has been inconsistent. This paper aims to summarize the available literature regarding GERD prevalence following laparoscopic sleeve gastrectomy, 8 studies demonstrate increased GERD prevalence, and 5 demonstrate decreased GERD prevalence following laparoscopic sleeve gastrectomy. The relationship between GERD and SG is complex and no clear relationship exists. The anatomic and physiologic changes caused by laparoscopic sleeve gastrectomy are discussed in the context of these inconsistent results.
Obesity is a worldwide epidemic. In 2008 the World Health Organization estimated that more than 500 million adults are clinically obese (BMI > 30 kg/m2) worldwide . Obese patients develop obesity-related comorbidities including type 2 diabetes mellitus (T2DM), hypertension, dyslipidemia, coronary artery disease, certain types of cancer, and gastroesophageal reflux disease (GERD) [2–6]. Healthcare providers must consider a treatment’s effect on weight loss, as well as its impact on obesity-related comorbidities. Bariatric surgery, in conjunction with intensive lifestyle interventions and medical treatments, has been shown to produce marked weight loss and improvement in many obesity-related comorbidities . Laparoscopic sleeve gastrectomy (SG) is effective in producing weight loss and improving T2DM ; however, evidence of SG’s effect on GERD is inconsistent .
2. Gastroesophageal Reflux Disease (GERD) Background
The Montreal Classification defines GERD as a condition that develops when reflux of stomach contents in the esophagus causes troublesome symptoms or complications . Symptoms associated with GERD include heartburn, regurgitation, dysphagia, laryngitis, and chronic cough. Prolonged acid exposure within the esophagus can lead to histopathologic and structural changes such as peptic stricture and Barrett’s esophagus.
The fundamental inciting event in GERD is the retrograde movement of gastric contents into the esophagus . A number of physiological factors increase the likelihood of this event, namely: transient lower esophageal sphincter relaxations [12–14], a hypotensive (or relatively hypotensive) lower esophageal sphincter (LES) , and anatomic disruption of the gastroesophageal junction (e.g., a hiatal hernia) [16–18]. The interplay between these elements has not been well elucidated, although it has been suggested that transient lower esophageal sphincter relaxations are responsible for mild symptoms, and more severe symptoms are due to the other two factors .
Transient lower esophageal sphincter relaxations, a hypotensive LES, and hiatal hernia are associated with obesity. Ayazi et al. demonstrated that increased weight was associated with both esophageal acid exposure and mechanical dysfunction of the LES . Wu et al. reported an association between obesity and frequency of transient lower esophageal sphincter relaxation .
The diagnosis of GERD is imprecise as there is no gold standard . Recently published practice guidelines state that a diagnosis of GERD can be established in the setting of typical symptoms . Given the lack of gold standard in GERD diagnosis, evaluation of GERD includes a variety of modalities including 24-hour esophageal pH monitoring, esophageal manometry, endoscopy, and symptom reporting [24, 25]. Studies assessing GERD often use symptom reporting as a primary endpoint, though others focus on more objective measures such as esophageal pH monitoring.
3. Sleeve Gastrectomy
SG was developed in 1988 as the initial procedure in a staged approach to patients with morbid obesity . It was described as an isolated procedure in 1993 by Johnston et al.  with a minimally invasive alternative developed in 1999 . SG has gained popularity since then as a definitive bariatric surgical procedure [29, 30].
SG involves resection of the greater curvature of the stomach and preservation of the pyloric valve and gastroesophageal junction. This maintains patency of the proximal alimentary tract and provides a restrictive and biochemical impetus for weight loss [31–33]. An advantage of SG compared to other bariatric procedures is that it does not involve an anastomosis. SG was initially considered a purely restrictive weight-loss procedure but there is newer evidence that alteration in gastrointestinal hormones plays a role. These changes are manifested by a decrease in endogenous ghrelin (a hormone associated with hunger) production  and decreased gastric and small bowel transit times .
4. Sleeve Gastrectomy and Gastroesophageal Reflux
Bariatric surgical procedures such as laparoscopic Roux-en-Y gastric bypass (RYGB) have been shown to improve symptoms related to GERD . However, the effect of SG on GERD remains controversial. The current literature can be divided into two categories: those that demonstrate an increase in GERD prevalence after SG (Table 1) and those that demonstrate a decrease in GERD prevalence after SG (Table 2).
4.1. SG Associated with an Increase in GERD Prevalence
The measured increase in GERD prevalence ranged from 2.1% to 34.9% in the analyzed literature. There was marked heterogeneity between the studies in regard to a number of factors including preoperative BMI, method of evaluating GERD, exclusion criteria, length of follow-up, and operative technique.
Two studies, Arias et al.  and Braghetto et al. , excluded patients with GERD preoperatively. Arias et al. , a single institution retrospective chart review conducted over 26 months, demonstrated a 2.1% incidence of GERD after SG. Braghetto et al.  conducted a single institution study that excluded patients with GERD preoperatively and reported an incidence of 27.5% after SG. Followup was not clearly reported and it is not stated whether the study was conducted prospectively. It is reasonable to assume that the modest 2.1% incidence of GERD cases reported by Arias et al.  would have been offset by a decrease in existing GERD if patients with GERD preoperatively were not excluded. The 27.5% increase reported by Braghetto et al.  may have been sufficient to cause an overall increase in GERD regardless of exclusion criteria.
Both works of Carter et al.  and Howard et al.  were single institution retrospective chart reviews focused on the relationship between GERD and SG. Carter et al.  presented 176 patients and recorded weight loss at 6, 12, and 24 months. Data for GERD was presented in two categories: early (symptoms occurring in the first 30 days) and late (symptoms occurring after 30 days). Early post-SG GERD prevalence was increased 14.4% from the preoperative value, and late post-SG GERD was increased by 12.6%. Howard et al.  demonstrated a 14% increase with a mean follow-up time of 32 weeks.
Himpens et al.  was a retrospective single institution study that described a triphasic response to GERD. An initial increase at one year, followed by a decrease at three years, and an increase at six years. Other studies lack the follow-up necessary to assess for this third phase. For example, Melissas et al. , a single centre prospective study, showed the same initial two phases (an increase followed by a decrease at two years) but did not have a sufficient follow-up time to evaluate for a possible third peak in GERD prevalence.
The work of Nocca et al.  was a multicenter prospective study that recruited 163 patients and demonstrated a 5.7% increase in prevalence after SG. The work of Tai et al.  was a prospective trial, but was performed at a single institution and a single surgeon conducted all operations. Preoperative BMI was the lowest among all presented studies at 36.3 kg/m2. This corresponded with a 34.9% increase in GERD prevalence, the largest increase in GERD prevalence of any studies listed.
The work of Lakdawala et al.  was a single institution retrospective study designed to compare SG with RYGB. It provided data that demonstrated a 4% increase in GERD prevalence after SG.
4.1.1. Proposed Mechanisms for Increased GERD Prevalence after SG (Table 3)
The anatomy of the after SG stomach can predispose one to GERD. The angle of His, an anatomical feature protective against GERD , is disrupted. Himpens et al.  describe its destruction during SG as partially responsible for the increase in GERD in the first year after SG, and its restoration as responsible for the decrease in GERD seen by year three of their study. Volume and pressure assessments performed by Yehoshua et al.  have demonstrated decreased gastric compliance and increased gastric pressures after SG. Increased gastric pressure leads to a relative hypotension of the LES and may lead to increased reflux.
A late anatomic change in SG patients called “neofundus” formation has been described by Himpens et al. . Neofundus formation refers to the dilation of the sleeve to an extent where normal physiological compliance is exceeded. The dilation of the neofundus effectively creates a mid-stomach stenosis in SG patients. This may lead to gastric stasis and increased acid production.
Incompetence of sling fibres near the angle of His correlates with a decrease in LES tone [48, 58]; these fibres are often transected in sleeve gastrectomy. Hypotension of the LES after SG has been confirmed by Braghetto et al.  using esophageal manometry.
Migration of the stomach into the chest (i.e., hiatal hernia) lessens the influence of the diaphragm on LES tone and leads to decreased LES pressures . Baumann et al.  describe 10 of 27 patients developing intrathoracic sleeve migration after SG.
Hypomotility and dysmotility of the gastrointestinal tract may cause GERD. Decreased plasma ghrelin levels have been shown to cause gastrointestinal dysmotility in animal models and are seen after SG . A decreased plasma ghrelin can then predispose patients to GERD . Delayed gastric emptying leads to an increase in stomach volume and pressure. Eventually increasing pressure can overcome the LES and lead to reflux. At one year after SG Himpens et al.  demonstrated slowed gastric emptying. This stands in contrast to their own measurements in SG patients three years postoperatively as well as the results reported by Melissas et al.  and Braghetto et al.  at one year.
4.2. Decreased GERD Prevalence after SG
GERD prevalence decreased between 2.8% and 20% in the analyzed literature. Like the papers demonstrating increased GERD prevalence, there was a significant amount of heterogeneity between the studies. The study with the largest decrease in GERD prevalence was Weiner et al. , a prospective single centre study. It demonstrated a 20% decrease in GERD prevalence.
Melissas et al. [32, 33] were both single centre prospective studies. Melissas et al.  demonstrated a decrease in GERD after SG at its terminal followup (24 months) while its 6-month analysis demonstrated a 21.7% increase in prevalence. Melissas et al.  reported a 5% decrease in GERD prevalence after SG.
Although the studies presented in Table 2 describe an overall decrease in GERD, all but Weiner et al.  encountered patients with de novo GERD following their operation. The decrease in prevalence was due to a greater resolution of GERD in patients with the disease before SG compared to development of new GERD in patients with no prior symptoms.
4.2.1. Proposed Mechanisms for Decreased GERD Prevalence after SG (Table 4)
Given that obesity has been shown to increase GERD , any weight loss associated with SG should reduce the effect of obesity on GERD symptoms.
Delayed gastric emptying can cause increases in stomach volume and pressure; therefore, accelerated gastric emptying should decrease stomach pressures. Melissas et al.  and Shah et al.  provided evidence that SG speeds gastric emptying. In contrast, Himpens et al.  demonstrated slowed gastric emptying at one year after SG. The alteration of sleeve anatomy postoperatively may decrease GERD. Stretching of the sleeve returns it to a more physiological level of compliance than in the immediate postoperative period . Increased compliance may lead to decreased gastric pressures. Tension on the gastric walls below the cardia should be reduced after SG according to LaPlace’s law (a lower diameter leads to lower wall tension if pressure is maintained) . Eventual restoration of the angle of His  can decrease GERD symptoms as the angle of His is an anatomical feature protective against GERD . Lazoura et al.  demonstrated that certain sleeve shapes correlated with decreased reflux symptoms. The resection of fundus in SG results in removal of the majority of the stomach’s parietal cells. Parietal cells are the major acid producing cells in the stomach  and their removal may decrease gastric acid production.
5. Hiatal Hernia, SG, and GERD
The relationship between hiatal hernia, SG, and GERD warrants discussion. Studies utilizing this combined technique were not included above, nor in the recent systematic analysis by Chiu et al. . Results have been promising. Daes et al. , a prospective single centre study, utilized hiatal hernia repair concurrently with SG and had a resultant 47.5% decrease in GERD prevalence postoperatively at 6 and 12 months. Soricelli et al.  demonstrated no de novo cases of GERD in any of the 97 patients undergoing SG and hiatal hernia repair. Even in cases where no hiatal hernia repair was planned the dissection involved in SG can function to reduce any hiatal hernia via traction applied during routine dissection. This was evidenced by the fact that in Daes et al.  of the 65 HH diagnosed preoperatively 31 had been reduced through the dissection associated with SG at the time of operation. Recognition and planned repair of hiatal hernia concurrently with SG may be one of the major technical factors in reducing post-SG GERD in the future.
Currently, the effect of SG on GERD remains controversial. In addition there remains marked heterogeneity among the studies assessing GERD following SG. Assessment using a common objective standard for the evaluation of GERD, such as 24-hour pH monitoring, is lacking. Differences in surgical technique among studies may also contribute to difficulty comparing GERD following SG in the literature. Randomized controlled trials are needed with both objective and subjective measures of GERD to clarify this controversy in the future.
- World Health Organisation, “Overweight and Obesity. Factsheet no. 311,” 2012, http://www.who.int/mediacentre/.
- T. L. S. Visscher and J. C. Seidell, “The public health impact of obesity,” Annual Review of Public Health, vol. 22, pp. 355–375, 2001.
- F. X. Pi-Sunyer, “Medical hazards of obesity,” Annals of Internal Medicine, vol. 119, no. 7, pp. 655–660, 1993.
- A. Must, J. Spadano, E. H. Coakley, A. E. Field, G. Colditz, and W. H. Dietz, “The disease burden associated with overweight and obesity,” Journal of the American Medical Association, vol. 282, no. 16, pp. 1523–1529, 1999.
- A. E. Field, E. H. Coakley, A. Must et al., “Impact of overweight on the risk of developing common chronic diseases during a 10-year period,” Archives of Internal Medicine, vol. 161, no. 13, pp. 1581–1586, 2001.
- A. Lukanova, O. Björ, R. Kaaks et al., “Body mass index and cancer: results from the Northern Sweden Health and Disease Cohort,” International Journal of Cancer, vol. 118, no. 2, pp. 458–466, 2006.
- P. R. Schauer, S. R. Kashyap, K. Wolski et al., “Bariatric surgery versus intensive medical therapy in obese patients with diabetes,” New England Journal of Medicine, vol. 366, no. 17, pp. 1567–1576, 2012.
- R. S. Gill, D. W. Birch, X. Shi, A. M. Sharma, and S. Karmali, “Sleeve gastrectomy and type 2 diabetes mellitus: a systematic review,” Surgery for Obesity and Related Diseases, vol. 6, no. 6, pp. 707–713, 2010.
- S. Chiu, D. W. Birch, X. Shi, A. M. Sharma, and S. Karmali, “Effect of sleeve gastrectomy on gastroesophageal reflux disease: a systematic review,” Surgery for Obesity and Related Diseases, vol. 7, no. 4, pp. 510–515, 2011.
- N. Vakil, S. V. Van Zanten, P. Kahrilas et al., “The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus,” American Journal of Gastroenterology, vol. 101, no. 8, pp. 1900–1943, 2006.
- J. P. P. Moraes-Filho, I. Cecconello, J. Gama-Rodrigues et al., “Brazilian consensus on gastroesophageal reflux disease: proposals for assessment, classification, and management,” American Journal of Gastroenterology, vol. 97, no. 2, pp. 241–248, 2002.
- J. Dent, W. J. Dodds, and R. H. Friedman, “Mechanism of gastroesophageal reflux in recumbent asymptomatic human subjects,” Journal of Clinical Investigation, vol. 65, no. 2, pp. 256–267, 1980.
- W. J. Dodds, J. Dent, and W. J. Hogan, “Mechanisms of gastroesophageal reflux in patients with reflux esophagitis,” New England Journal of Medicine, vol. 307, no. 25, pp. 1547–1552, 1982.
- R. K. Mittal, R. H. Holloway, R. Penagini, L. A. Blackshaw, and J. Dent, “Transient lower esophageal sphincter relaxation,” Gastroenterology, vol. 109, no. 2, pp. 601–610, 1995.
- J. Dent, W. J. Dodds, W. J. Hogan, and J. Toouli, “Factors that influence induction of gastroesophageal reflux in normal human subjects,” Digestive Diseases and Sciences, vol. 33, no. 3, pp. 270–275, 1988.
- R. K. Mittal, D. F. Rochester, and R. W. McCallum, “Sphincteric action of the diaphragm during a relaxed lower esophageal sphincter in humans,” American Journal of Physiology, vol. 256, no. 1, p. G139, 1989.
- J. E. Pandolfino, H. Kim, S. K. Ghosh, J. O. Clarke, Q. Zhang, and P. J. Kahrilas, “High-resolution manometry of the EGJ: an analysis of crural diaphragm function in GERD,” American Journal of Gastroenterology, vol. 102, no. 5, pp. 1056–1063, 2007.
- S. Sloan, A. W. Rademaker, and P. J. Kahrilas, “Determinants of gastroesophageal junction incompetence: Hiatal Hernia, lower esophageal sphincter, or both?” Annals of Internal Medicine, vol. 117, no. 12, pp. 977–982, 1992.
- C. P. Barham, D. C. Gotley, A. Mills, and D. Alderson, “Precipitating causes of acid reflux episodes in ambulant patients with gastro-oesophageal reflux disease,” Gut, vol. 36, no. 4, pp. 505–510, 1995.
- S. Ayazi, J. A. Hagen, L. S. Chan et al., “Obesity and gastroesophageal reflux: quantifying the association between body mass index, esophageal acid exposure, and lower esophageal sphincter status in a large series of patients with reflux symptoms,” Journal of Gastrointestinal Surgery, vol. 13, no. 8, pp. 1440–1447, 2009.
- J. C. Wu, L. Mui, C. M. Cheung, Y. Chan, and J. J. Sung, “Obesity Is Associated With Increased Transient Lower Esophageal Sphincter Relaxation,” Gastroenterology, vol. 132, no. 3, pp. 883–889, 2007.
- P. Moayyedi and N. J. Talley, “Gastro-oesophageal reflux disease,” Lancet, vol. 367, no. 9528, pp. 2086–2100, 2006.
- P. O. Katz, L. B. Gerson, and M. F. Vela, “Guidelines for the diagnosis and management of gastroesophageal reflux disease,” The American Journal of Gastroenterology, vol. 108, pp. 308–328, 2013.
- G. A. Ergun and P. J. Kahrilas, “Clinical applications of esophageal manometry and pH monitoring,” American Journal of Gastroenterology, vol. 91, no. 6, pp. 1077–1089, 1996.
- B. Avidan, A. Sonnenberg, T. G. Schnell, and S. J. Sontag, “There are no reliable symptoms for erosive oesophagitis and Barrett's oesophagus: endoscopic diagnosis is still essential,” Alimentary Pharmacology and Therapeutics, vol. 16, no. 4, pp. 735–742, 2002.
- D. S. Hess and D. W. Hess, “Biliopancreatic diversion with a duodenal switch,” Obesity Surgery, vol. 8, no. 3, pp. 267–282, 1998.
- D. Johnston, J. Dachtler, H. M. Sue-Ling, R. F. G. J. King, and I. G. Martin, “The Magenstrasse and Mill operation for morbid obesity,” Obesity Surgery, vol. 13, no. 1, pp. 10–16, 2003.
- A. A. Gumbs, M. Gagner, G. Dakin, and A. Pomp, “Sleeve gastrectomy for morbid obesity,” Obesity Surgery, vol. 17, no. 7, pp. 962–969, 2007.
- J. L. Colquitt, J. Picot, E. Loveman, and A. J. Clegg, “Surgery for obesity,” Cochrane Database of Systematic Reviews, no. 2, Article ID CD003641, 2009.
- E. Akkary, A. Duffy, and R. Bell, “Deciphering the sleeve: technique, indications, efficacy, and safety of sleeve gastrectomy,” Obesity Surgery, vol. 18, no. 10, pp. 1323–1329, 2008.
- F. B. Langer, M. A. R. Hoda, A. Bohdjalian et al., “Sleeve gastrectomy and gastric banding: effects on plasma ghrelin levels,” Obesity Surgery, vol. 15, no. 7, pp. 1024–1029, 2005.
- J. Melissas, S. Koukouraki, J. Askoxylakis et al., “Sleeve gastrectomy: a restrictive procedure?” Obesity Surgery, vol. 17, no. 1, pp. 57–62, 2007.
- J. Melissas, M. Daskalakis, S. Koukouraki et al., “Sleeve gastrectomy-a “food limiting” operation,” Obesity Surgery, vol. 18, no. 10, pp. 1251–1256, 2008.
- S. N. Karamanakos, K. Vagenas, F. Kalfarentzos, and T. K. Alexandrides, “Weight loss, appetite suppression, and changes in fasting and postprandial ghrelin and peptide-YY levels after Roux-en-Y gastric bypass and sleeve gastrectomy: a prospective, double blind study,” Annals of surgery, vol. 247, no. 3, pp. 401–407, 2008.
- I. Braghetto, C. Davanzo, O. Korn et al., “Scintigraphic evaluation of gastric emptying in obese patients submitted to sleeve gastrectomy compared to normal subjects,” Obesity Surgery, vol. 19, no. 11, pp. 1515–1521, 2009.
- C. Tai, Y. Lee, M. Wu et al., “The effect of roux-en-Y gastric bypass on gastroesophageal reflux disease in morbidly obese chinese patients,” Obesity Surgery, vol. 19, no. 5, pp. 565–570, 2009.
- E. Arias, P. R. Martínez, V. Ka Ming Li, S. Szomstein, and R. J. Rosenthal, “Mid-term follow-up after sleeve gastrectomy as a final approach for morbid obesity,” Obesity Surgery, vol. 19, no. 5, pp. 544–548, 2009.
- I. Braghetto, A. Csendes, E. Lanzarini, K. Papapietro, C. Cárcamo, and J. C. Molina, “Is laparoscopic sleeve gastrectomy an acceptable primary bariatric procedure in obese patients? Early and 5-year postoperative results,” Surgical Laparoscopy Endoscopy & Percutaneous Techniques, vol. 22, no. 6, pp. 479–486, 2012.
- P. R. Carter, K. A. Leblanc, M. G. Hausmann, K. P. Kleinpeter, S. N. Debarros, and S. M. Jones, “Association between gastroesophageal reflux disease and laparoscopic sleeve gastrectomy,” Surgery for Obesity and Related Diseases, vol. 7, no. 5, pp. 569–572, 2011.
- J. Himpens, J. Dobbeleir, and G. Peeters, “Long-term results of laparoscopic sleeve gastrectomy for obesity,” Annals of Surgery, vol. 252, no. 2, pp. 319–324, 2010.
- D. D. Howard, A. M. Caban, J. C. Cendan, and K. Ben-David, “Gastroesophageal reflux after sleeve gastrectomy in morbidly obese patients,” Surgery for Obesity and Related Diseases, vol. 7, no. 6, pp. 709–713, 2011.
- M. A. Lakdawala, A. Bhasker, D. Mulchandani, S. Goel, and S. Jain, “Comparison between the results of laparoscopic sleeve gastrectomy and laparoscopic roux-en-y gastric bypass in the Indian population: a retrospective 1 year study,” Obesity Surgery, vol. 20, no. 1, pp. 1–6, 2010.
- D. Nocca, D. Krawczykowsky, B. Bomans et al., “A prospective multicenter study of 163 sleeve gastrectomies: results at 1 and 2 years,” Obesity Surgery, vol. 18, no. 5, pp. 560–565, 2008.
- C. M. Tai, C. K. Huang, Y. C. Lee, C. Y. Chang, C. T. Lee, and J. T. Lin, “Increase in gastroesophageal reflux disease symptoms and erosive esophagitis 1 year after laparoscopic sleeve gastrectomy among obese adults,” Surgical Endoscopy, vol. 27, no. 4, pp. 1260–1266, 2013.
- A. Chopra, E. Chao, Y. Etkin, L. Merklinger, J. Lieb, and H. Delany, “Laparoscopic sleeve gastrectomy for obesity: can it be considered a definitive procedure?” Surgical Endoscopy and Other Interventional Techniques, vol. 26, no. 3, pp. 831–837, 2012.
- L. Rawlins, M. P. Rawlins, C. C. Brown, and D. L. Schumacher, “Sleeve gastrectomy: 5 year outcomes of a single institution,” Surgery for Obesity and Related Diseases, vol. 9, no. 1, pp. 21–25, 2013.
- R. A. Weiner, S. Weiner, I. Pomhoff, C. Jacobi, W. Makarewicz, and G. Weigand, “Laparoscopic sleeve gastrectomy—influence of sleeve size and resected gastric volume,” Obesity Surgery, vol. 17, no. 10, pp. 1297–1305, 2007.
- I. Braghetto, E. Lanzarini, O. Korn, H. Valladares, J. C. Molina, and A. Henriquez, “Manometric changes of the lower esophageal sphincter after sleeve gastrectomy in obese patients,” Obesity Surgery, vol. 20, no. 3, pp. 357–362, 2010.
- J. Himpens, G. Dapri, and G. B. Cadière, “A prospective randomized study between laparoscopic gastric banding and laparoscopic isolated sleeve gastrectomy: results after 1 and 3 years,” Obesity Surgery, vol. 16, no. 11, pp. 1450–1456, 2006.
- R. T. Yehoshua, L. A. Eidelman, M. Stein et al., “Laparoscopic Sleeve gastrectomy—volume and pressure assessment,” Obesity Surgery, vol. 18, no. 9, pp. 1083–1088, 2008.
- M. Nahata, S. Muto, N. Oridate, et al., “Impaired ghrelin signaling is associated with gastrointestinal dysmotility in rats with gastroesophageal reflux disease,” American Journal of Physiology-Gastrointestinal and Liver Physiology, vol. 303, no. 1, pp. G42–G53, 2012.
- O. Lazoura, D. Zacharoulis, G. Triantafyllidis et al., “Symptoms of gastroesophageal reflux following laparoscopic sleeve gastrectomy are related to the final shape of the sleeve as depicted by radiology,” Obesity Surgery, vol. 21, no. 3, pp. 295–299, 2011.
- T. Baumann, J. Grueneberger, G. Pache et al., “Three-dimensional stomach analysis with computed tomography after laparoscopic sleeve gastrectomy: sleeve dilation and thoracic migration,” Surgical Endoscopy and Other Interventional Techniques, vol. 25, no. 7, pp. 2323–2329, 2011.
- J. Melissas, A. Leventi, I. Klinaki et al., “Alterations of global gastrointestinal motility after sleeve gastrectomy,” Annals of Surgery, 2012.
- S. Shah, P. Shah, J. Todkar, M. Gagner, S. Sonar, and S. Solav, “Prospective controlled study of effect of laparoscopic sleeve gastrectomy on small bowel transit time and gastric emptying half-time in morbidly obese patients with type 2 diabetes mellitus,” Surgery for Obesity and Related Diseases, vol. 6, no. 2, pp. 152–157, 2010.
- S. Santoro, “Technical aspects in sleeve gastrectomy,” Obesity Surgery, vol. 17, no. 11, pp. 1534–1535, 2007.
- J. L. Lortat-Jacob and F. Robert, “Les malpositions cardiotubérositaires,” Archives Françaises des Maladies de l'appareil Digestif, vol. 42, pp. 750–774, 1953.
- O. Korn, A. Csendes, P. Burdiles, I. Braghetto, and H. J. Stein, “Anatomic dilatation of the cardia and competence of the lower esophageal sphincter: a clinical and experimental study,” Journal of Gastrointestinal Surgery, vol. 4, no. 4, pp. 398–406, 2000.
- P. J. Kahrilas, S. Lin, J. Chen, and M. Manka, “The effect of hiatus hernia on gastro-oesophageal junction pressure,” Gut, vol. 44, no. 4, pp. 476–482, 1999.
- X. Yao and J. G. Forte, “Cell Biology of Acid Secretion by the Parietal Cell,” Annual Review of Physiology, vol. 65, pp. 103–131, 2003.
- J. Daes, M. E. Jimenez, N. Said, J. C. Daza, and R. Dennis, “Laparoscopic sleeve gastrectomy: symptoms of gastroesophageal reflux can be reduced by changes in surgical technique,” Obesity Surgery, vol. 22, no. 12, pp. 1874–1879, 2012.
- E. Soricelli, A. Iossa, G. Casella, F. Abbatini, B. Calì, and N. Basso, “Sleeve gastrectomy and crural repair in obese patients with gastroesophageal reflux disease and/or Hiatal Hernia,” Surgery for Obesity and Related Diseases, vol. 9, no. 3, pp. 356–361, 2013.